{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:21:09Z","timestamp":1791217269739,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"crossref","award":["10756"],"award-info":[{"award-number":["10756"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["201169"],"award-info":[{"award-number":["201169"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["261365"],"award-info":[{"award-number":["261365"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Sanit\u00e0","doi-asserted-by":"publisher","award":["RFPS-2006-3-337923"],"award-info":[{"award-number":["RFPS-2006-3-337923"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Sanit\u00e0","doi-asserted-by":"publisher","award":["RFPS-2007-1-636647"],"award-info":[{"award-number":["RFPS-2007-1-636647"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004008","name":"Istituto Superiore di Sanit\u00e0","doi-asserted-by":"crossref","award":["AIDS-2008"],"award-info":[{"award-number":["AIDS-2008"]}],"id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["7245\/1"],"award-info":[{"award-number":["7245\/1"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2010LC747T-004"],"award-info":[{"award-number":["2010LC747T-004"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ateneo Sapienza","award":["2009-C26A09PELN"],"award-info":[{"award-number":["2009-C26A09PELN"]}]},{"name":"Ateneo Sapienza","award":["2010-C26A1029ZS"],"award-info":[{"award-number":["2010-C26A1029ZS"]}]},{"name":"Ateneo Sapienza","award":["2011-C26A11BYWP"],"award-info":[{"award-number":["2011-C26A11BYWP"]}]},{"name":"Ateneo Sapienza","award":["2012-C26A12JL55"],"award-info":[{"award-number":["2012-C26A12JL55"]}]},{"name":"Ateneo Sapienza","award":["2013-C26A13T8PS"],"award-info":[{"award-number":["2013-C26A13T8PS"]}]},{"name":"Fondo per gli investimenti di ricerca di base","award":["RBAP10TPXK"],"award-info":[{"award-number":["RBAP10TPXK"]}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["13535"],"award-info":[{"award-number":["13535"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["3603 2010\/12"],"award-info":[{"award-number":["3603 2010\/12"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"FISM","doi-asserted-by":"crossref","award":["2011\/R\/4"],"award-info":[{"award-number":["2011\/R\/4"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondazione Italiana per la Ricerca sull\u2019Artrite"},{"DOI":"10.13039\/501100009531","name":"Istituto Italiano di Tecnologia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009531","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RBFR12I3UB_002"],"award-info":[{"award-number":["RBFR12I3UB_002"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cgfr.co.uk","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.cytogfr.2014.10.012","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T13:13:41Z","timestamp":1414761221000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Divergent effects of type-I interferons on regulatory T cells"],"prefix":"10.1016","volume":"26","author":[{"given":"Silvia","family":"Piconese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pacella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Timperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Barnaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2014.10.012_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (alpha\/beta) in immunity and autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonzalez-Navajas","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0020","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0025","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ni.2683","article-title":"T cells in nonlymphoid tissues","volume":"14","author":"Burzyn","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0035","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI28941","article-title":"Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo","volume":"116","author":"Vukmanovic-Stejic","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0040","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2008-01-132951","article-title":"Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells","volume":"112","author":"Hippen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0045","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.27188","article-title":"Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue","volume":"60","author":"Piconese","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0050","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.4049\/jimmunol.0900526","article-title":"APC activation by IFN-alpha decreases regulatory T cell and enhances Th cell functions","volume":"184","author":"Pace","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI22996","article-title":"Toll-like receptor 9-induced type I IFN protects mice from experimental colitis","volume":"115","author":"Katakura","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2012.03.042","article-title":"Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice","volume":"143","author":"Lee","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0065","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.4049\/jimmunol.1301093","article-title":"Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis","volume":"191","author":"Kole","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.10.014","article-title":"IFN-beta induces the proliferation of CD4+ CD25+ Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis","volume":"242","author":"Chen","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI36604","article-title":"PD-L1 negatively regulates CD4+ CD25+ Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV","volume":"119","author":"Franceschini","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fimmu.2013.00247","article-title":"Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancer","volume":"4","author":"Burocchi","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0085","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1002\/eji.201141700","article-title":"Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells","volume":"41","author":"Burocchi","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0090","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1172\/JCI65180","article-title":"Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation","volume":"123","author":"Stewart","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0095","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1158\/0008-5472.CAN-12-3788","article-title":"Interferon-alpha suppresses cAMP to disarm human regulatory T cells","volume":"73","author":"Bacher","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/art.23268","article-title":"Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells","volume":"58","author":"Yan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2567.2010.03280.x","article-title":"Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses","volume":"131","author":"Golding","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0110","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves\u2019 disease","volume":"186","author":"Mao","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0115","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1158\/0008-5472.CAN-11-3468","article-title":"Impaired IFN-alpha production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression","volume":"72","author":"Sisirak","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20131556","article-title":"Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection","volume":"211","author":"Srivastava","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0125","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.4049\/jimmunol.1401039","article-title":"IFNalphaR signaling in effector but not regulatory T cells is required for immune dysregulation during Type I IFN-dependent inflammatory disease","volume":"193","author":"Srivastava","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/eji.201243265","article-title":"Induction, control, and plasticity of Treg cells: the immune regulatory network revised","volume":"43","author":"Barnaba","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0135","doi-asserted-by":"crossref","first-page":"18995","DOI":"10.1073\/pnas.1113301108","article-title":"IFN-alpha and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells","volume":"108","author":"Le Buanec","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0140","first-page":"39","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0150","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.171.1.285","article-title":"IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3","volume":"171","author":"Ziegler-Heitbrock","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4049\/jimmunol.174.1.99","article-title":"Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells","volume":"174","author":"Dikopoulos","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nm.3485","article-title":"FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS","volume":"20","author":"Liu","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) FoxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/imr.12175","article-title":"Lineage stability and phenotypic plasticity of Foxp3(+) regulatory T cells","volume":"259","author":"Hori","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0180","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.immuni.2012.05.031","article-title":"T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2","volume":"37","author":"Koch","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0185","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.1200413","article-title":"IFN-gamma production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease","volume":"189","author":"Koenecke","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0190","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20110236","article-title":"IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis","volume":"208","author":"Zhao","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0195","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","article-title":"Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection","volume":"31","author":"Oldenhove","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0200","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0205","doi-asserted-by":"crossref","first-page":"e56209","DOI":"10.1371\/journal.pone.0056209","article-title":"Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals","volume":"8","author":"Du","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0210","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0215","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1521-4141(200107)31:7<2026::AID-IMMU2026>3.0.CO;2-U","article-title":"Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity","volume":"31","author":"Byrnes","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/76940","article-title":"Interferon alpha\/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox","volume":"1","author":"Nguyen","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri1552","article-title":"Roles of interferon-regulatory factors in T-helper-cell differentiation","volume":"5","author":"Lohoff","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2013.01.009","article-title":"DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes","volume":"41","author":"Wang","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/gene.2011.21","article-title":"IRF7: activation, regulation, modification and function","volume":"12","author":"Ning","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0245","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4049\/jimmunol.181.3.1673","article-title":"IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression","volume":"181","author":"Fragale","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2006.09.012","article-title":"Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis","volume":"182","author":"de Andres","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.08.007","article-title":"Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+ CD25+ Foxp3 expression in subjects with multiple sclerosis","volume":"215","author":"Vandenbark","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0260","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.10.013","article-title":"Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study","volume":"218","author":"Namdar","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000274976","article-title":"Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C","volume":"53","author":"Akiyama","year":"2010","journal-title":"Intervirology"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0270","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2893.2010.01317.x","article-title":"A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low\/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment","volume":"18","author":"Soldevila","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00535-011-0466-y","article-title":"Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients","volume":"47","author":"Kanto","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0280","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2008.05.020","article-title":"Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy","volume":"49","author":"Burton","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0285","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0463.2010.02586.x","article-title":"Circulating Toll-like receptor (TLR) 2 TLR4, and regulatory T cells in patients with chronic hepatitis C","volume":"118","author":"Wang J-PP","year":"2010","journal-title":"APMIS: Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0290","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12330","article-title":"Imbalance of regulatory T cells and Th17 cells in patients with chronic hepatitis C","author":"Hao","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0295","doi-asserted-by":"crossref","first-page":"8314","DOI":"10.1158\/1078-0432.CCR-08-0705","article-title":"Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17","volume":"14","author":"Wang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0300","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2011-03-340992","article-title":"Increase in circulating CD4(+)CD25(+)Foxp3(+) T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-alpha","volume":"118","author":"Riley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0305","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1479-5876-8-76","article-title":"Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment","volume":"8","author":"Ascierto","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0310","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.1401109","article-title":"Therapeutic activity of high-dose intratumoral IFN-beta requires direct effect on the tumor vasculature","volume":"193","author":"Spaapen","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0320","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0325","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0330","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/jhep.2003.50105","article-title":"Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C","volume":"37","author":"Ji","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0335","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2014.10.012_bib0340","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610114001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610114001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:26:22Z","timestamp":1717514782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610114001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1359610114001403"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2014.10.012","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent effects of type-I interferons on regulatory T cells","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}